Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / NHS Savings from Pediatric Tablet Switch
Regulatory medical study

NHS Savings from Pediatric Tablet Switch

Analysis based on 7 articles · First reported Apr 09, 2026 · Last updated Apr 10, 2026

Sentiment
40
Attention
2
Articles
7
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The study's findings suggest a significant cost-saving opportunity for the United Kingdom===National Health Service, potentially freeing up resources within the healthcare system. Pharmaceutical companies producing Diazoxide in liquid form might see a decrease in demand, while those producing tablets could see an increase.

Pharmaceuticals Healthcare
Event Summary

A study conducted by Great Ormond Street Hospital has revealed that prescribing children with congenital hyperinsulinism (CHI) tablets instead of liquid Diazoxide could save the United Kingdom===National Health Service approximately £40,000 per patient annually. The research, involving 19 patients aged seven to 13, demonstrated that children successfully switched to tablets and often preferred them due to taste and convenience. Liquid Diazoxide costs £15.50 per 50mg, while tablets cost only £1.15 per 50mg. This change not only offers substantial financial benefits but also significantly improves the quality of life for patients like Jess Manktelow, who found the tablets easier to manage. Great Ormond Street Hospital plans to further assess the viability of this switch for children as young as four.

Key Actions
85 United Kingdom===National Health Service could save money by switching medication format
60 Jess Manktelow switched to tablet medication
Entities Involved
govactor
United Kingdom===National Health Service
The United Kingdom===National Health Service stands to save significant amounts of money, estimated at £40,000 per patient per year, by switching from liquid to tablet forms of medication for conditions like congenital hyperinsulinism. This change could lead to millions in savings across the healthcare system.
Importance 90 Sentiment 50
cmdt
Diazoxide
Diazoxide is the medication central to the study, used to stabilize blood sugar levels in children with congenital hyperinsulinism. The significant cost difference between its liquid (£15.50 per 50mg) and tablet (£1.15 per 50mg) forms is the primary driver of the potential savings for the United Kingdom===National Health Service.
Importance 80 Sentiment 30
per
Jess Manktelow
Jess Manktelow, an 11-year-old patient with congenital hyperinsulinism, participated in the Great Ormond Street Hospital study and experienced significant improvements in her quality of life after switching to Diazoxide tablets. Her positive experience underscores the patient benefits of the medication format change.
Importance 60 Sentiment 20
per
Antonia Dastamani
Dr. Antonia Dastamani, a consultant at Great Ormond Street Hospital, co-led the project, emphasizing the importance of patient involvement in treatment decisions and the unexpected quality-of-life improvements observed.
Importance 50 Sentiment 20
per
Kate Morgan
Kate Morgan, a clinical nurse specialist at Great Ormond Street Hospital, co-led the project, highlighting the unanticipated scale of quality-of-life improvements for children and their families.
Importance 50 Sentiment 20
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.